• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

决定腹水对传统治疗难治性的因素。

Factors that determine refractoriness of ascites to conventional therapy.

作者信息

Amra S, Elie R, Kronborg I

出版信息

CMAJ. 1986 Sep 1;135(5):481-6.

PMID:3742389
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1491553/
Abstract

We compared the charts of 33 patients who had refractory ascites with those of 33 patients who had responsive ascites to identify factors responsible for resistance to conventional therapy. The results of biochemical tests of liver function were more abnormal in the responsive group than in the refractory group on admission to hospital, whereas the results of kidney function tests were worse in the refractory group. The transhepatic portal pressure was similar in the 7 patients with refractory ascites and the 11 patients with responsive ascites in whom it was measured. The portal vein pressure as calculated from the difference in albumin content between the serum and the ascitic fluid was similar in the two groups, as were the findings at histologic examination of the liver. We conclude that neither the severity of the liver disease nor the portal pressure is a critical factor in the development of refractory ascites. Kidney dysfunction, however, is important, but its mechanism remains unclear.

摘要

我们比较了33例难治性腹水患者与33例反应性腹水患者的病历,以确定导致对传统治疗产生抵抗的因素。入院时,反应性腹水组的肝功能生化检查结果比难治性腹水组更异常,而难治性腹水组的肾功能检查结果更差。在测量经肝门静脉压力的7例难治性腹水患者和11例反应性腹水患者中,该压力相似。两组中根据血清与腹水白蛋白含量差异计算出的门静脉压力相似,肝脏组织学检查结果也相似。我们得出结论,肝病的严重程度和门静脉压力都不是难治性腹水发生的关键因素。然而,肾功能不全很重要,但其机制仍不清楚。

相似文献

1
Factors that determine refractoriness of ascites to conventional therapy.决定腹水对传统治疗难治性的因素。
CMAJ. 1986 Sep 1;135(5):481-6.
2
The value of serum-ascites albumin gradient for the determination of portal hypertension in the diagnosis of ascites.血清腹水白蛋白梯度在腹水诊断中用于确定门静脉高压的价值。
Hepatogastroenterology. 2001 Jan-Feb;48(37):166-8.
3
Refractory ascites in chronic dialysis patients.慢性透析患者的顽固性腹水
Clin Nephrol. 1974;2(2):59-62.
4
Refractory ascites due to portal vein thrombosis in liver cirrhosis--report of two cases.肝硬化门静脉血栓形成所致难治性腹水——两例报告
Hepatogastroenterology. 1998 Sep-Oct;45(23):1777-80.
5
Correlation between increased colloid osmotic pressure and the resolution of refractory ascites after transjugular intrahepatic portosystemic shunt.经颈静脉肝内门体分流术后胶体渗透压升高与顽固性腹水消退之间的相关性
South Med J. 2000 Mar;93(3):305-9.
6
Liver resection and intractable postoperative ascites.肝切除术与顽固性术后腹水
Hepatogastroenterology. 1993 Feb;40(1):14-6.
7
Correlation between portal/hepatic vein gradient and response to transjugular intrahepatic portosystemic shunt creation in refractory ascites.门静脉/肝静脉梯度与经颈静脉肝内门体分流术治疗顽固性腹水疗效的相关性
J Vasc Interv Radiol. 2004 Dec;15(12):1431-4. doi: 10.1097/01.RVI.0000141341.98441.0E.
8
Splanchnic hemodynamic factors in cirrhosis with refractory ascites.肝硬化伴顽固性腹水的内脏血流动力学因素
J Lab Clin Med. 1979 Feb;93(2):301-9.
9
[Endogenous digitalis-like factor in liver cirrhosis and cholestasis].[肝硬化和胆汁淤积中的内源性类洋地黄因子]
Z Gastroenterol. 1993 Feb;31 Suppl 2:20-3.
10
The MELD score in advanced liver disease: association with clinical portal hypertension and mortality.晚期肝病中的终末期肝病模型(MELD)评分:与临床门静脉高压症及死亡率的关联
Exp Clin Transplant. 2006 Jun;4(1):395-9.

引用本文的文献

1
Two cases of refractory ascites associated with dill pickle ingestion.两例与食用莳萝泡菜相关的顽固性腹水病例。
Dig Dis Sci. 2000 Jun;45(6):1119-20. doi: 10.1023/a:1005506220369.
2
Manipulation of ascitic fluid pressure in cirrhotics to optimize hemodynamic and renal function.通过控制肝硬化患者的腹水压力来优化血流动力学和肾功能。
Ann Surg. 1988 Oct;208(4):504-11. doi: 10.1097/00000658-198810000-00012.

本文引用的文献

1
INTRAHEPATIC VENO-OCCLUSIVE DISEASE IN CIRRHOSIS WITH CHRONIC ASCITES: DIAGNOSIS BY HEPATIC PHLEBOGRAPHY AND RESULTS OF SURGICAL TREATMENT.肝硬化伴慢性腹水的肝内静脉闭塞性疾病:经肝静脉造影诊断及外科治疗结果
Ann Surg. 1963 Sep;158(3):370-82. doi: 10.1097/00000658-196309000-00006.
2
Long-term medical management and complications of 'resistant' ascites.“顽固性”腹水的长期医学管理及并发症
Gut. 1961 Dec;2(4):285-96. doi: 10.1136/gut.2.4.285.
3
Cirrhosis with ascites: hemodynamic observations.肝硬化伴腹水:血流动力学观察
Ann Surg. 1962 Jan;155(1):147-52. doi: 10.1097/00000658-196201000-00017.
4
The treatment of ascites by side to side portacaval shunt.侧侧门腔分流术治疗腹水
Ann Surg. 1959 Sep;150(3):428-44. doi: 10.1097/00000658-195909000-00008.
5
The pathogenesis of ascites and a consideration of its treatment.腹水的发病机制及其治疗的思考。
Surg Gynecol Obstet. 1954 Oct;99(4):385-91.
6
Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis.肝硬化中的肝脏血流动力学与肾素-血管紧张素-醛固酮系统
Gastroenterology. 1980 Jan;78(1):92-9.
7
Natriuretic hormone and the sodium retention of cirrhosis.利钠激素与肝硬化的钠潴留
Gastroenterology. 1981 Aug;81(2):395-7.
8
A comparison of acute reversible pre- and postsinusoidal portal hypertension on salt and water retention in the dog.犬急性可逆性窦前和窦后门静脉高压对水钠潴留影响的比较。
Hepatology. 1982 Jan-Feb;2(1):54-8. doi: 10.1002/hep.1840020109.
9
Renal kallikrein excretion in alcoholic cirrhosis. Relationship to other vasoactive systems.酒精性肝硬化患者的肾激肽释放酶排泄。与其他血管活性系统的关系。
Am J Gastroenterol. 1981 Mar;75(3):183-7.
10
Serum protein concentration and portal pressure determine the ascitic fluid protein concentration in patients with chronic liver disease.血清蛋白浓度和门静脉压力决定了慢性肝病患者腹水的蛋白浓度。
J Lab Clin Med. 1983 Aug;102(2):260-73.